GI
GAMMA Investing Portfolio holdings
AUM
$1.58B
1-Year Return
23.44%
This Quarter Return
+3.43%
1 Year Return
+23.44%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$1.17B
AUM Growth
+$164M
(+16%)
Cap. Flow
+$159M
Cap. Flow
% of AUM
13.53%
Top 10 Holdings %
Top 10 Hldgs %
25.72%
Holding
3,876
New
301
Increased
2,412
Reduced
770
Closed
100
Top Buys
| 1 |
Apple
AAPL
|
+$7.64M |
| 2 |
NVIDIA
NVDA
|
+$5.67M |
| 3 |
Microsoft
MSFT
|
+$5.57M |
| 4 |
Amazon
AMZN
|
+$4.68M |
| 5 |
Tesla
TSLA
|
+$3.77M |
Top Sells
| 1 |
Johnson & Johnson
JNJ
|
+$945K |
| 2 |
Exxon Mobil
XOM
|
+$738K |
| 3 |
HCA Healthcare
HCA
|
+$688K |
| 4 |
MRO
Marathon Oil Corporation
MRO
|
+$634K |
| 5 |
Amgen
AMGN
|
+$531K |
Sector Composition
| 1 | Technology | 24.92% |
| 2 | Financials | 12.5% |
| 3 | Consumer Discretionary | 8.81% |
| 4 | Healthcare | 7.95% |
| 5 | Industrials | 7.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2076
Calavo Growers
CVGW
$489M
| $16K | ﹤0.01% |
629
+24
| +4% | +$612 |
|
2077
Edgewell Personal Care
EPC
$1.01B
| $16K | ﹤0.01% |
476
+75
| +19% | +$2.52K |
|
2078
Mesa Laboratories
MLAB
$339M
| $16K | ﹤0.01% |
121
-2
| -2% | -$264 |
|
2079
Coty
COTY
$3.57B
| $16K | ﹤0.01% |
2,292
+1,779
| +347% | +$12.4K |
|
2080
Arcutis Biotherapeutics
ARQT
$2.07B
| $15.9K | ﹤0.01% |
1,140
+83
| +8% | +$1.16K |
|
2081
Verint Systems
VRNT
$1.23B
| $15.8K | ﹤0.01% |
574
+20
| +4% | +$549 |
|
2082
Madrigal Pharmaceuticals
MDGL
$9.63B
| $15.7K | ﹤0.01% |
51
+25
| +96% | +$7.71K |
|
2083
Enterprise Products Partners
EPD
$68.8B
| $15.7K | ﹤0.01% |
500
| – | – |
|
2084
1st Source
SRCE
$1.55B
| $15.6K | ﹤0.01% |
268
+60
| +29% | +$3.5K |
|
2085
Blue Owl Capital
OWL
$12.2B
| $15.6K | ﹤0.01% |
672
+213
| +46% | +$4.95K |
|
2086
O-I Glass
OI
$1.99B
| $15.6K | ﹤0.01% |
1,441
-961
| -40% | -$10.4K |
|
2087
Ziff Davis
ZD
$1.5B
| $15.6K | ﹤0.01% |
287
+205
| +250% | +$11.1K |
|
2088
Autoliv
ALV
$9.68B
| $15.6K | ﹤0.01% |
166
+15
| +10% | +$1.41K |
|
2089
Bank of N.T. Butterfield & Son
NTB
$1.89B
| $15.5K | ﹤0.01% |
425
+203
| +91% | +$7.42K |
|
2090
Altimmune
ALT
$321M
| $15.5K | ﹤0.01% |
2,147
-220
| -9% | -$1.59K |
|
2091
Bridgewater Bancshares
BWB
$457M
| $15.5K | ﹤0.01% |
1,145
-11
| -1% | -$149 |
|
2092
Emergent Biosolutions
EBS
$434M
| $15.4K | ﹤0.01% |
1,614
-96
| -6% | -$918 |
|
2093
Riley Exploration Permian
REPX
$608M
| $15.3K | ﹤0.01% |
480
+172
| +56% | +$5.49K |
|
|
FL
2094
DELISTED
Foot Locker
FL
| $15.3K | ﹤0.01% |
704
+344
| +96% | +$7.49K |
|
2095
PAR Technology
PAR
$1.79B
| $15.3K | ﹤0.01% |
210
+70
| +50% | +$5.09K |
|
2096
Huntsman Corp
HUN
$1.89B
| $15.3K | ﹤0.01% |
846
+406
| +92% | +$7.32K |
|
2097
Utz Brands
UTZ
$1.12B
| $15.2K | ﹤0.01% |
973
+324
| +50% | +$5.07K |
|
|
LGF.A
2098
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
| $15.2K | ﹤0.01% |
1,784
+766
| +75% | +$6.54K |
|
2099
First Advantage
FA
$2.75B
| $15.2K | ﹤0.01% |
812
-47
| -5% | -$880 |
|
2100
Disc Medicine
IRON
$2.08B
| $15.2K | ﹤0.01% |
239
+139
| +139% | +$8.81K |
|